GERARD STROUP: Open Payments
NPI 1730195058 · MIDDLETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,195 in 66 payments from 11 companies in 2025. Trend: 2023 $1,727 · 2024 $1,812 · 2025 $1,195
Food & beverage: $1,088Education: $107
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 31 | $471 |
| Novartis Pharmaceuticals Corporation | 12 | $184 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| UCB, Inc. | 4 | $101 |
| LEO Pharma Inc. | 4 | $99 |
| GENZYME CORPORATION | 2 | $57 |
| Galderma Laboratories, L.P. | 2 | $40 |
| Amgen Inc. | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
Products named: TREMFYA, DUPIXENT, COSENTYX, Bimzelx, ANZUPGO, NEMLUVIO, OTEZLA, Rhapsido.
Industry payments across DE — which companies pay providers there.
